Our approach

The unique value proposition offered by Aging Analytics Agency is deeply connected to our use of tangible and quantifiable metrics to perform near-future industry forecasting, giving weight and substance to the projections, insights and conclusions derived from our analytical reports.

In particular, we took the most proven quantifiable framework for estimating how close a given technology is to market-readiness, namely the use of TRLs, which is a method commonly used in the technology industry generally and the aerospace industry particularly, and applied it for the first time to the life sciences industry in order to create a framework through which we can more quantifiably project when certain technologies relating to Longevity, Personalized and Preventive Medicine, and Advanced Biomedicine can expect to reach the level of maturity required to enable its practical application in the clinic.

Technology Readiness Levels (TRLs) enable the gauging of the maturity of Critical Technology Elements (CTEs) determined during a Technology Readiness Assessment (TRA) that examines program concepts, technology requirements, and demonstrated technology capabilities. TRL use a ranking 1 - 9, with 9 being the most mature technology, with specific TRL levels being assigned to specific technologies by a group of scientific experts familiar with each specific technology. The use of TRLs enables consistent, uniform discussions of technical maturity across different types of technology.

In the coming years, TRLs can underpin efforts to shed light on the most important technologies, but also those that are at present furthest away from their practical application; therefore enabling the right timing and focus to ensure the accomplishment of specific endpoints with regard to each emerging technology, and the interactions that are possible between technologies that are currently at different points on the TRL scale, but can be expected to merge in level over the coming few years.

Using TRLs can expedite progress in the coming 5 years by employing TRLs to provide an objective lens through which various technologies are viewed. In the same way that using this scale has benefited the aerospace industry, it can bolster the efforts of the life sciences industry in the coming years.

As a concrete example, in our analytical report “Global Longevity Industry Landscape Overview Volume II: The Business of Longevity, we applied the concept of TRLs to 120+ emerging topics in geroscience R&D today as well as 50+ practical applications of geroscience today, to serve as the basis for a more precise and comprehensive framework to analyzing and landscaping the field of geroscience and the longevity industry.

The TRLs for the current state of progress can arguably be broken down as follows:

The application of TRL to the geroscience, longevity and disruptive bioscience industries will serve as an important step toward: